Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Saudi Medical Journal. 2006; 27 (10): 1523-1525
Dans Anglais | IMEMR | ID: emr-80607

Résumé

Production of fetal proteins by malignant tissue is a recognized phenomenon seen in many neoplastic disorders. Hence, the aim was to determine if there is a positive correlation between administration of chemotherapy and reduction in fetal hemoglobin [HbF] levels. In a prospective study at the University of Benin Teaching Hospital, Nigeria, 50 cancer patients at various stages of the disease and 50 controls for 10 months period [March to December, 2005], HbF was determined in pre- chemotherapy [n=23] and post-chemotherapy [n=27] cancer patients. Fetal hemoglobin was estimated by the modified Betke's method. A total of 20 patients [40%] comprising 10 pre-chemotherapy and 10 post-chemotherapy patients presented with increased HbF which was statistically significant [p<0.0001]. There was also a significant decrease in post- chemotherapy result when both pre and post-chemotherapy values were compared [p=0.0073]. The results presented indicate that during recovery of erythropoiesis some erythroblasts synthesized HbF and there was a reduction following administration of chemotherapy


Sujets)
Humains , Mâle , Femelle , Tumeurs/sang , Protocoles de polychimiothérapie antinéoplasique/sang , Études prospectives , Sédimentation du sang/effets des médicaments et des substances chimiques , Sédimentation du sang/analyse , Résultat thérapeutique , Hémoglobine foetale/effets des médicaments et des substances chimiques
SÉLECTION CITATIONS
Détails de la recherche